正在加载 ETF 研究
正在获取最新的基金概况、持仓和市场数据。
正在加载 ETF 研究
正在获取最新的基金概况、持仓和市场数据。
New York Stock Exchange ArcaETF
US$165.65
−US$18.17 · -9.88%
截至 10月12日 15:45 ET
盘中时间采用ET。市场数据可能有所延迟。
The MRNX fund is designed to generate returns by taking a leveraged, bullish stance on the daily share price movements of Moderna, Inc. (MRNA). It achieves this primarily through the use of swap agreements and short-term listed call options. Its objective is to deliver a daily return equivalent to 200% (twice) the daily percentage change in MRNA's stock price, which it maintains through daily rebalancing. However, holding the fund for periods exceeding a single day may lead to actual returns that deviate significantly from this 2x daily target, influenced by factors like market volatility, compounding, and rebalancing impacts. For collateral supporting its derivative contracts, MRNX may also invest in stable assets such as U.S. government securities, money market funds, short-term bond exchange-traded funds (ETFs), and investment-grade corporate debt.
基金资料更新于 2026年10月12日。
当日区间
当前US$165.65
52 周区间
—
1 个月
+103.48%
3 个月
+324.85%
成立以来
+712.81%
累计价格变动不包括分红，以及投资者特定的税费、交易成本和现金流。
显示已报告的 10 项持仓中的 10 项
持仓数据更新于 2026年10月12日。
以下研究数据暂时不可用：新闻和敞口。
在 GoAI 中继续
结合更广泛的市场背景，在 GoAI 中继续研究此 ETF。
ETF 数据可能延迟或不完整，也可能在发布后被修正。持仓和敞口会随时间变化。历史表现不保证未来结果。本页面仅供信息和教育用途，不构成投资建议或推荐。
